MORN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Morningstar Inc (MORN) is not a strong buy for a beginner investor with a long-term focus at this moment. While the company has shown some growth in revenue and gross margin, its net income has declined slightly, and recent analyst ratings have lowered price targets due to concerns about competition and AI strategy. Additionally, technical indicators are neutral, and there are no strong proprietary trading signals or significant positive catalysts to justify immediate action.
The MACD histogram is positive at 1.384, suggesting a mild bullish trend, but it is contracting. RSI is neutral at 43.612, indicating no clear overbought or oversold condition. Moving averages are converging, showing indecision in price direction. Key support is at 169.115, and resistance is at 189.812, with the current pre-market price of 179.61 near the pivot level of 179.464.
Hedge funds are significantly increasing their positions, with a 395.58% increase in buying over the last quarter. Morningstar's plans to enhance its market index design and liquidity assessment methods for large IPOs like SpaceX could position the company well for future growth.
Analysts have lowered price targets due to decelerating growth in key platforms like Morningstar Direct and PitchBook, as well as challenges from competition and AI strategy. Insiders show no significant trading activity, and there are no recent congress trading data or influential figure transactions to support a buy decision.
In Q4 2025, Morningstar's revenue increased by 8.48% YoY to $641.1M, and gross margin improved by 2.40% to 53.78%. However, net income dropped by 1.54% to $115.1M, and EPS grew modestly by 3.69% to 2.81. While growth trends are positive in some areas, the decline in net income raises concerns.
Recent analyst actions include BMO Capital lowering the price target to $193 from $257 while maintaining an Outperform rating, and UBS reducing the price target to $280 from $320 with a Buy rating. Analysts cite concerns about competition, sales cycles, and AI strategy as reasons for the adjustments.
